Search results for "epilepsy"

showing 10 items of 420 documents

Sturge-Weber syndrome: a report of 14 cases

2013

Sturge-Weber-Krabe syndrome (SWS), also known as encephalotrigeminalangiomatosis and named the forthfacomatosis, recall the names of the authors who first describedit in its basic clinical, radiological andanatomopathological aspects. We report here 14 cases of Sturge-Weber disease. In 6 of these, despite what had been previously described in literature, an extension of the angioma has been noted in other parts of the body. The study of these subjects stresses not only the need for a pharmacological/neuropsychomotor intervention, but alsothe need of a psychotherapeutic approach, for the emotional and affective implications thatcould derive from this syndrome. The reported cases are similar …

Sturge-Weber syndrome encephalotrigeminalangiomatosis epilepsy neurocutaneous syndrome.Pediatricsmedicine.medical_specialtylcsh:RC435-571Sturge–Weber syndromelcsh:MedicineCase ReportSturge-Weber syndromeDiseaseAngiomaEpilepsyIntervention (counseling)lcsh:PsychiatrymedicineencephalotrigeminalangiomatosisRecallbusiness.industryNeurological statuslcsh:Rmedicine.diseaseSettore MED/39 - Neuropsichiatria InfantilePsychiatry and Mental healthSturge-Webersyndrome encephalotrigeminalangiomatosis epilepsy neurocutaneous syndromeepilepsyneurocutaneous syndromebusinessMental Illness
researchProduct

THERAPEUTIC EFFICACY OF MAGNESIUM VALPROATE IN SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY

2012

Succinic semialdehyde dehydrogenase deficiency (SSADHD or gammahydroxybutyric aciduria), a disorder of γ-aminobutyric acid (GABA) metabolism, manifests as a slowly progressive or static encephalopathy. The latter encompasses prominent cognitive dysfunction, neuropsychiatric morbidity and epilepsy.We report safe and effective treatment with MgVPA in an adolescent female with SSADHD and seizures refractory to a broad spectrum of antiepileptics. MgVPA therapy (20 mg/Kg/day) was introduced at 7 years based upon behavioural difficulties and EEG alterations without adverse effects. Therapy was halted at age 13 years, and reintroduced at 14 years, due to new onset complex partial seizures. EEG dem…

Succinic semialdehyde dehydrogenase deficiencySSADHDbusiness.industrySymptomatic seizuresTHERAPEUTIC EFFICACY OF MAGNESIUM VALPROATE IN SUCCINIC SEMIALDEHYDE DEHYDROGENASEStatus epilepticusPharmacologymedicine.diseaseSettore MED/39 - Neuropsichiatria InfantileArticleBroad spectrumEpilepsyNeurodevelopmental disorderConcomitantMAGNESIUM VALPROATEmedicinemedicine.symptomGABAMgVPAbusinessMagnesium Valproate
researchProduct

A Guide to Designing a Memory fMRI Paradigm for Pre-surgical Evaluation in Temporal Lobe Epilepsy

2020

There has been increasing interest in the clinical and experimental use of memory functional Magnetic Resonance Imaging (fMRI). The 2017 American Academy of Neurology practice guidelines on the use of pre-surgical cognitive fMRI suggests that verbal memory fMRI could be used to lateralize memory functions in people with Temporal Lobe Epilepsy (TLE) and should be used to predict post-operative verbal memory outcome. There are however technical and methodological considerations, to optimize both the sensitivity and specificity of this imaging modality. Below we discuss these constraints and suggest recommendations to consider when designing a memory fMRI paradigm.

TLEgenetic structuresguiderecallbehavioral disciplines and activities050105 experimental psychologylcsh:RC346-429Temporal lobememory03 medical and health sciencesEpilepsy0302 clinical medicinemedicineMemory functions0501 psychology and cognitive scienceslcsh:Neurology. Diseases of the nervous systemModality (human–computer interaction)medicine.diagnostic_testRecall05 social sciencesfMRICognitionparadigmmedicine.diseasenervous systemNeurologyPerspectivemethodNeurology (clinical)Verbal memoryrecognitionPsychologyFunctional magnetic resonance imaging030217 neurology & neurosurgerypsychological phenomena and processesCognitive psychologyFrontiers in Neurology
researchProduct

ROLE OF NITRIC OXIDE/cGMP PATHWAY IN CANNABINOID MODULATION OF PAROXYSMAL PHENOMENA

TRPV1temporal lobe epilepsy modelnitric oxidehippocampus.cannabinoidelectrophysiologySettore BIO/09 - Fisiologiabehaviourcannabinoids; nitric oxide; TRPV1; temporal lobe epilepsy models; electrophysiology; behaviour; hippocampus.
researchProduct

Time, frequency and information domain analysis of short-term heart rate variability before and after focal and generalized seizures in epileptic chi…

2019

OBJECTIVE In this work we explore the potential of combining standard time and frequency domain indexes with novel information measures, to characterize pre- and post-ictal heart rate variability (HRV) in epileptic children, with the aim of differentiating focal and generalized epilepsy regarding the autonomic control mechanisms. APPROACH We analyze short-term HRV in 37 children suffering from generalized or focal epilepsy, monitored 10 s, 300 s, 600 s and 1800 s both before and after seizure episodes. Nine indexes are computed in time (mean, standard deviation of normal-to-normal intervals, root mean square of the successive differences (RMSSD)), frequency (low-to-high frequency power rati…

TachycardiaMalefocal epilepsymedicine.medical_specialtyPhysiology0206 medical engineeringBiomedical EngineeringBiophysicsHeart Rate Variability02 engineering and technologyAutonomic Nervous SystemSettore ING-INF/01 - ElettronicaStandard deviation03 medical and health sciencesEpilepsy0302 clinical medicineHeart RateSeizuresPhysiology (medical)Internal medicinemedicineHeart rate variabilityHumansClinical significanceGeneralized epilepsyChildgeneralized epilepsybusiness.industryLinear discriminant analysismedicine.disease020601 biomedical engineeringTime–frequency analysisSettore ING-INF/06 - Bioingegneria Elettronica E InformaticaCardiologyFemalemedicine.symptombusinesscomplexity030217 neurology & neurosurgery
researchProduct

Activation of glycine receptors modulates spontaneous epileptiform activity in the immature rat hippocampus

2014

While the expression of glycine receptors in the immature hippocampus has been shown, no information about the role of glycine receptors in controlling the excitability in the immature CNS is available. Therefore, we examined the effect of glycinergic agonists and antagonists in the CA3 region of an intact corticohippocampal preparation of the immature (postnatal days 4-7) rat using field potential recordings. Bath application of 100 μM taurine or 10 μM glycine enhanced the occurrence of recurrent epileptiform activity induced by 20 μM 4-aminopyridine in low Mg(2+) solution. This proconvulsive effect was prevented by 3 μM strychnine or after incubation with the loop diuretic bumetanide (10 …

TaurinePhysiologyTaurineGlycinePharmacologyHippocampuschemistry.chemical_compoundNeuroscience: Development/Plasticity/RepairReceptors GlycinemedicineAnimalsRats WistarReceptorGlycine receptorCells CulturedEpilepsyChemistryGABAA receptorStrychnineRatsBiochemistrynervous systemAnimals NewbornGlycineGabazineAnticonvulsantsBumetanidemedicine.drug
researchProduct

Satisfaction with and reliability of in-hospital video-EEG monitoring systems in epilepsy diagnosis – A German multicenter experience

2021

OBJECTIVE: To analyze satisfaction with and reliability of video-electroencephalography-monitoring systems (VEMS) in epilepsy diagnostics.; METHODS: A survey was conducted between December 2020 and January 2021 among German epilepsy centers using well-established customer satisfaction (CS) and quality assurance metrics.; RESULTS: Among 16 participating centers, CS with VEMS was low, with only 13% of customers actively recommending their system. Only 50% of users were satisfied with the overall performance of their VEMS, and a low 18% were satisfied with the manufacturer's customer service. User interface, software stability, lack of regular updates, and missing customer-oriented improvement…

TelemedicineComputer scienceData managementmedia_common.quotation_subjectVideo Recording050105 experimental psychology03 medical and health sciences0302 clinical medicineGermanyPhysiology (medical)Humans0501 psychology and cognitive sciencesQuality (business)Operations managementReliability (statistics)media_commonInpatientsEpilepsybusiness.industry05 social sciencesReproducibility of ResultsHealth technologyElectroencephalographyNeurophysiological MonitoringHospitalsTelemedicineSensory SystemsNeurologyVEMSPatient SatisfactionCustomer satisfactionNeurology (clinical)businessQuality assurance030217 neurology & neurosurgeryClinical Neurophysiology
researchProduct

Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions

2011

SummaryTuberous Sclerosis Complex (TSC) is a multisystem genetic disorder characterized by hamartomatous neurological lesions that exhibit abnormal cell proliferation and differentiation. Hyperactivation of mTOR pathway by mutations in either the Tsc1 or Tsc2 gene underlies TSC pathogenesis, but involvement of specific neural cell populations in the formation of TSC-associated neurological lesions remains unclear. We deleted Tsc1 in Emx1-expressing embryonic telencephalic neural stem cells (NSCs) and found that mutant mice faithfully recapitulated TSC neuropathological lesions, such as cortical lamination defects and subependymal nodules (SENs). These alterations were caused by enhanced gen…

Telencephaloncongenital hereditary and neonatal diseases and abnormalitiesCellular differentiationNeuroepithelial CellsEmbryonic DevelopmentBiologyTuberous Sclerosis Complex 1 Proteinmurine modelCerebral VentriclesMiceNeural Stem CellsCell MovementTuberous SclerosismedicineGeneticsAnimalsAnimals; Animals Newborn; Cell Differentiation; Cell Movement; Cell Proliferation; Cerebral Ventricles; Embryonic Development; Embryonic Stem Cells; Epilepsy; Gene Silencing; Gene Targeting; Megalencephaly; Mice; Mutation; Neural Stem Cells; Neuroepithelial Cells; Neurons; TOR Serine-Threonine Kinases; Telencephalon; Tuberous Sclerosis; Tuberous Sclerosis Complex 1 Protein; Tumor Suppressor Proteins; Signal TransductionGene SilencingNeural cellPI3K/AKT/mTOR pathwayEmbryonic Stem CellsCell ProliferationNeuronsEpilepsymTOR; Neural Stem Cells; Tuberous Sclerosis; murine modelTOR Serine-Threonine KinasesTumor Suppressor ProteinsCell DifferentiationCell BiologyNewbornEmbryonic stem cellNeural stem cellMegalencephalyCell biologynervous system diseasesNeuroepithelial cellmedicine.anatomical_structureAnimals NewbornImmunologyGene TargetingMutationmTORMolecular MedicineTSC1TSC2Signal Transduction
researchProduct

α-Synuclein expression levels do not significantly affect proteasome function and expression in mice and stably transfected PC12 cell lines

2004

α-Synuclein (α-syn) is a small protein of unknown function that is found aggregated in Lewy bodies, the histopathological hallmark of sporadic Parkinson disease and other synucleinopathies. Mutations in the α-syn gene and a triplication of its gene locus have been identified in early onset familial Parkinson disease. α-Syn turnover can be mediated by the proteasome pathway. A survey of published data may lead to the suggestion that overexpression of α-syn wild type, and/or their variants (A53T and A30P), may produce a decrease in proteasome activity and function, contributing to α-syn aggregation. To investigate the relationship between synuclein expression and proteasome function we have s…

Time Factorsanimal diseasesmedicine.disease_causePC12 CellsBiochemistryMicechemistry.chemical_compoundTransgenesPromoter Regions GeneticMice KnockoutGeneticsMutationInnervationBrainParkinson DiseaseProteasome complexAmyloidosisCell biologyInnervacióalpha-SynucleinAdditions and CorrectionsPèptidsPlasmidsProteasome Endopeptidase ComplexPrionsProtein subunitBlotting WesternImmunoblottingSynucleinsMice TransgenicNerve Tissue ProteinsBiologyTransfectionBacterial ProteinsMultienzyme ComplexesmedicineAnimalsImmunoprecipitationMolecular BiologyAlpha-synucleinSynucleinopathiesEpilepsyWild typeGenetic VariationCell BiologyAxonsRatsnervous system diseasesMice Inbred C57BLEpilèpsiaDisease Models AnimalLuminescent ProteinschemistryProteasomenervous systemSinapsiMutationSynapsesSynucleinAmiloïdosiPeptides
researchProduct

Topiramate and Metabolic Acidosis in Infants and Toddlers

2002

Summary:  Purpose: Topiramate (TPM) inhibits carbonic anhydrase, with metabolic acidosis as a possible side effect, although this has been reported in only two adult cases. We investigated the acid–base metabolism in infants and toddlers treated with TPM. Methods: Nine infants and toddlers aged 5 months to 2.3 years (median, 6 months) were treated with TPM at maximal doses of 8.2–26 mg/kg/day (median, 11 mg/kg/day). The maximal TPM dose was achieved after 8–35 days (median, 17 days). TPM was given in addition to other antiepileptic drugs (AEDs) in five cases and as a sole AED in four patients with refractory epilepsy resistant to multiple AEDs. The diagnoses were infantile spasms (n = 5), e…

Topiramatemedicine.medical_specialtyEpilepsia partialis continuaFructoseAcid–base homeostasisDrug Administration ScheduleTopiramateHyperventilationmedicineHumansAcidosisAcid-Base EquilibriumEpilepsyDose-Response Relationship Drugbusiness.industryMetabolic disorderAge FactorsInfantMetabolic acidosisHydrogen-Ion Concentrationmedicine.diseaseSurgeryBicarbonatesTreatment OutcomeNeurologyChild PreschoolAnesthesiaAnticonvulsantsBase excessNeurology (clinical)Blood Gas Analysismedicine.symptomAcidosisbusinessFollow-Up Studiesmedicine.drugEpilepsia
researchProduct